Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT.
Parthasarathy, S., Henry, K., Pei, H., Clayton, J., Rempala, M., Johns, D., De Frutos, O., Garcia, P., Mateos, C., Pleite, S., Wang, Y., Stout, S., Condon, B., Ashok, S., Lu, Z., Ehlhardt, W., Raub, T., Lai, M., Geeganage, S., Burkholder, T.P.(2018) Bioorg Med Chem Lett 28: 1887-1891
- PubMed: 29655979 
- DOI: 10.1016/j.bmcl.2018.03.092
- Primary Citation of Related Structures:  
6CCY - PubMed Abstract: 
During the course of our research efforts to develop potent and selective AKT inhibitors, we discovered enatiomerically pure substituted dihydropyridopyrimidinones (DHP) as potent inhibitors of protein kinase B/AKT with excellent selectivity against ROCK ...